Resistell AG
Revolutionary alternative for antibiotic susceptibility test
Resistell is revolutionizing Antibiotic Susceptibility Testing (AST) with the world’s fastest platform. Our CE IVD-certified AST for bloodstream infections has been validated in two clinical studies with over 500 patient samples, achieving more than 95% accuracy. The current version of our Phenotech device delivers ultra-rapid phenotypic AST results in just 2 hours—a speed unmatched by any other technology. To date, we have secured CHF 17 million in equity and CHF 4 million in grants. We are now raising funds for high-throughput device, leveraging our cutting-edge, highly de-risked nanomotion technology. The prototype of a high-throughput device, developed with an industrial partner, is ready for further advancement.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
01.09.2025
New Startup Innovation Projects set to advance their technologies (startupticker.ch)
03.04.2024
TechTour Growth: A showcase for Switzerland’s Deeptech prowess (startupticker.ch)
28.03.2024
New additions to startups’ board of directors (startupticker.ch)
19.03.2024
Resistell’s convincing study results published in Nature Communications (startupticker.ch)
18.12.2023
Twenty-eight startups selected for the Innosuisse Scale up Coaching (startupticker.ch)
No Jobs
Videos
Resistell Phenotech R&D launch
TOP 100 Swiss Startup Award
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Venture Leaders Life Sciences
The venture leaders - the members of the Swiss national startup team- have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.
Resistell AG
Revolutionary alternative for antibiotic susceptibility test
Website:
www.resistell.com
Headquarter:
Muttenz
Foundation Date:
April 2018
Technology:
- Medtech
Sectors:
- Hightech
- Diagnostics
- Healthcare infrastructure
- Micro technologies
- Nano technologies
- Infection
- Medical devices
- Medtech
Support received
